Ireland· IE-PA-PA1777/001/001
Mysoline 250mg Tablets
A primidone product containing primidone, registered in Ireland by Laboratoires SERB. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Primidone is registered in 17 of 19 countries.
Countries holding a registration under ATC N03AA03 (primidone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Primidone · ATC N03AA03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of primidone costs, country by country.
Normalised to the WHO defined daily dose (1.25 g), the median price runs from $0.86 in Italy to $2.61 in Switzerland — a ×3.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Primidone · price per daily dose (1.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.61
- FR France$0.88
- IT Italy$0.86
The record
At a glance
HPRA (Ireland)- Active substance
- Primidone
- Manufacturer
- Laboratoires SERB
- Country
- Ireland (IE)
- ATC code
- N03AA03
- ATC class
- Primidone
- Defined daily dose
- 1.25 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1777/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
424 interactions on record for primidone.
Graded by severity as the source publishes them — 129 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Primidone · interactions on record
424 records
- 129 severe
- 199 moderate
- 8 minor
- 53 info
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- NaldemedineA06AH05severe
- EliglustatA16AX10severe
35 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Primidone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEnodama 250mg tabletsDesitin Pharma Ltd
- United StatesMysolineBausch Health US, LLC
- FinlandMysolineAstraZeneca Oy
- NetherlandsMysoline tabletten 250 mgMedcor Pharmaceuticals B.V.
- NorwayLiskantinDesitin
- SwitzerlandMysoline, TablettenCuratis AG
- PolandMizodinZakłady Farmaceutyczne "UNIA" Spółdzielnia Pracy
- SwedenPrimidon Afortas 250 mg Tablett2care4 Generics ApS
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Mysoline
- Belgium · Mysoline
- Czechia · Liskantin
- Germany · Liskantin, Liskantin Saft
- Denmark · Primidon Afortas, Primidon Orifarm
- Estonia · Liskantin
- Spain · Mysoline
- Finland · Primidon Afortas
- France · Mysoline
- United Kingdom (Northern Ireland) · Enodama, Mysoline
- Hungary · Sertan
- Italy · Mysoline
- Luxembourg · Mysoline
- Malta · Mysoline, Primidone Serb
- Netherlands · Mysoline
- Norway · Primidon Afortas
- Poland · Mizodin
- Portugal · Mysoline
- Sweden · Primidon Afortas
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/045e7bf7-ee56-4a6c-b5dc-00ed91b20873 GET /v1/drugs/045e7bf7-ee56-4a6c-b5dc-00ed91b20873?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N03AA",
"N03AA03"
],
"strength": null,
"pa_number": "PA1777/001/001",
"substances": [
"Primidone"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1979",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about primidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.